Relevance of pH dependency on in vitro release of bromocriptine from a modified-release formulation.
Since pH profiles of the dissolution rate are thought to be predictive for the in vivo performance of oral modified-release formulations with respect to bioavailability and dose dumping with food, these pH profiles were established for a new modified-release (MR) formulation for bromocriptine (Parlodel SRO). The results show a marked decrease of bromocriptine dissolution with increasing pH of the dissolution medium. However, when measured in native human duodenal juice (pH 8.1), dissolution was significantly higher than when measured in buffer of comparable pH. In a human pharmacokinetic study, this MR formulation showed good bioavailability and no food effect on the pharmacokinetic profile. Therefore, pH profiles alone seem to have only a limited predictive power for the in vivo performance of this MR formulation for bromocriptine.
Drewe
J
J
Pharma Development, Sandoz Ltd., Basle, Switzerland.
Keck
M
M
Guitard
P
P
Pellet
A
A
Johnston
B
B
Beglinger
C
C
D001971:Bromocriptine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D004386:Duodenum / Q000378:metabolism; D005470:Fluorometry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007419:Intestinal Secretions / Q000378:metabolism; D008297:Male; D012995:Solubility
D003692:Delayed-Action Preparations; D001971:Bromocriptine